UNSPSC 51162341: Atropine/chlorpheniramine/phenylephrine/phenyltoloxamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162341 Atropine/chlorpheniramine/phenylephrine/phenyltoloxamine is a Commodity code under which state and local governments procure injectable pharmaceutical products and associated delivery services for correctional health systems, emergency medical response, and community health programs. The Washington State Department of Corrections is currently soliciting parenteral products including IV solutions, total parenteral nutrition (TPN), peripheral parenteral nutrition (PPN), and controlled substances for medically necessary healthcare to incarcerated individuals, requiring documented experience preparing and delivering IV solutions and adjusting PN preparations with strict delivery timelines (PN bags within 24 hours of order, other parenteral products within 8 hours). Seminole County, Florida is procuring naloxone units and drug deactivation systems for community health initiatives on an annual basis with quarterly deliveries. State correctional departments and county health departments are the primary issuing bodies under this code, with state agencies focusing on inpatient parenteral care delivery to correctional facilities and counties supporting community-wide emergency response and overdose prevention.

The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with responses due October 7, 2026, seeking suppliers for eight correctional facilities across three regions (West, Central, and East) and anticipating multiple award to up to three bidders per region through June 30, 2030; the solicitation encourages participation from small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%), with compliance required under Chapter 39.19 RCW and a 5% Small and Diverse Business Goal. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, with a two-year initial term and one-year renewal option. Recent activity concentrates in Washington and Florida; additional geographic spread across state correctional and county health systems remains unclear from the posted opportunities. Suppliers must meet state business licensure, background clearance, and insurance requirements, including Professional Liability coverage and commercial general liability naming the issuing agency as additional insured.